PAR paradigm biopharmaceuticals limited..

Ann: Investor Presentation - $66m Capital Raise, page-7

  1. 1,014 Posts.
    lightbulb Created with Sketch. 280
    Say 008 is positive - any idea what it would then take to prove to the FDA that we have DMOAD capability? The company have repeatedly said that 008 may not be enough. I wonder if the further requirements could be incorporated into 003?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.5¢
Change
-0.010(2.30%)
Mkt cap ! $168.9M
Open High Low Value Volume
43.5¢ 43.5¢ 40.5¢ $518.4K 1.233M

Buyers (Bids)

No. Vol. Price($)
8 17544 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 9850 1
View Market Depth
Last trade - 15.44pm 10/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.